FDA Approves Drug that Extends Survival in the Common Lung Cancer

By Peter Bracke | UCLA Jonsson on Dec 13, 2014   Health  

The U.S. Food and Drug Administration today approved a new drug to treat non-small-cell lung cancer (NSCLC), offering patients new hope in fighting this difficult disease. Lung cancer is expected to lead to over 150,000 deaths in the United States this year alone, and NSCLC accounts for about 85 percent of all lung cancers. The […]